ORGANOGENESIS HOLDINGS INC. Number of Reportable Segments
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Number of Reportable Segments of 1 Segments for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Segments, a 0.00% change year-over-year.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for the quarter ending 2025-03-31 was 1.00 Segments, a 0.00% change year-over-year.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for the quarter ending 2024-03-31 was 1.00 Segments, a 0.00% change year-over-year.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for the quarter ending 2023-03-31 was 1.00 Segments, a 0.00% change year-over-year.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for fiscal 2025 was 1.00 Segments, a 0.00% change from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for fiscal 2024 was 1.00 Segments, a 0.00% change from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for fiscal 2023 was 1.00 Segments, a 0.00% change from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. number of reportable segments for fiscal 2022 was 1.00 Segments, a 0.00% change from fiscal 2021.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segments 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 1.00 Segments 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 1.00 Segments 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 1.00 Segments 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 1.00 Segments 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | 1.00 Segments 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | 1.00 Segments 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.00 Segments 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 1.00 Segments 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 1.00 Segments 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | 1.00 Segments 10-K · filed 2024-02-29 | |||
| 2023-09-30 | 1.00 Segments 10-Q · filed 2023-11-09 | |||
| 2023-06-30 | 1.00 Segments 10-Q · filed 2023-08-09 | |||
| 2023-03-31 | 1.00 Segments 10-Q · filed 2023-05-10 | |||
| 2022-12-31 | 1.00 Segments 10-K · filed 2023-03-01 | |||
| 2022-09-30 | 1.00 Segments 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 1.00 Segments 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 1.00 Segments 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 1.00 Segments 10-K · filed 2022-03-01 | |||
| 2021-09-30 | 1.00 Segments 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | 1.00 Segments 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | 1.00 Segments 10-Q · filed 2021-05-11 | |||
| 2020-12-31 | 1.00 Segments 10-K · filed 2021-03-16 | |||
| 2019-12-31 | 1.00 Segments 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |